Transitional cell carcinoma (TCC) is the most common type of bladder cancer diagnosed, accounting for 90% of all bladder malignancies in North America, South America, Europe, and Asia. It’s reported that there were an estimated 386,300 new bladder cancer cases and 150,200 deaths in 2008 alone. And the number was up to 170,000 deaths in 2010…
Prof Boniol, Research Director at the International Prevention Research Institute (iPRI) and Professor at the Strathclyde Institute for Global Public Health at iPRI, Lyon, France, will tell the congress that the total harm men experience in terms of impotence and incontinence, and the side-effects from prostate cancer treatments, severely affects their quality of life, and should further discourage the use of PSA testing for prostate cancer screening. Prof Boniol will say: "The test measures PSA protein levels, which are produced by the prostate gland, in a man’s blood, and may help detect early cancer…
Dr Emberson said: "Despite recent declines in the numbers of people smoking and tar yields of cigarettes, smoking remains the leading preventable cause of death in Europe." He added: "Previous studies had demonstrated that prolonged cigarette smoking from early adult life was associated with about 10 years loss of life expectancy, with about one quarter of smokers killed by their habit before the age of 70. …
"Understanding this previously ignored part of the human genome, its role in human development, and how it may be taken over by disease, opens a new frontier in science with important implications for medical advances," said Philipp Kapranov, Ph.D., lead researcher at the St. …
source : http://www.foxnews.com/health/2013/06/27/are-chinese-herbs-safe-to-use/
source : http://www.foxnews.com/health/2013/06/26/heart-disease-deaths-show-dramatic-decline-in-europe/
source : http://www.foxnews.com/health/2013/06/21/cdc-prepares-for-potential-outbreak-deadly-mers-virus/
source : http://www.foxnews.com/health/2013/06/18/who-urges-tougher-food-marketing-rules-to-curb-childhood-obesity/
The world's population could reach 11 billion by the year 2100, according to a new statistical analysis. That represents 800 million more people than was forecast in 2011. Most of that increase comes because birth rates in Africa haven't dropped as fast as projected. “The fertility decline in Africa has slowed down or stalled to a larger extent than we previously predicted, and as a result the African population will go up,” said study co-author Adrian Raftery, a statistician at the University of Washington, in a statement. Ever increasing The United Nations reported that the population hit 7 billion in October 2011. That's an amazing increase from the mere 5 million people who lived on the planet in 8000 B.C. or the 1 billion who were alive in 1805. The huge surge in population is expected to cause mega-city populations to swell, which could worsen environmental problems and overcrowding. Right now, Africa's population stands at 1.1 billion, but that is expected to increase four-fold, to 4.2 billion, by 2100. Rest unchanged The rest of the world is unlikely to see big changes from the past estimate. Europe may see a slight dip in population, because it continues to have a below-replacement birth rate, meaning more people are dying than being born. The new analysis used a more sophisticated method for estimating life expectancy, updated fertility forecasting methods and new population data. The model predicts that the population will likely reach between 9 billion and 13 billion by 2100. By contrast, the U.N.'s population estimates assume the average birth rate may vary by up to 0.5 children per woman, which results in a large range for the world's population at the end of the century, between 7 billion and 17 billion. The findings suggest that experts should redouble their efforts to curb population growth in Africa, Raftery said. “These new findings show that we need to renew policies, such as increasing access to family planning and expanding education for girls, to address rapid population growth in Africa,” Raftery said in a statement. Top 10 Ways to Destroy Earth Earth in the Balance: 7 Crucial Tipping Points Crowded Planet: 7 (Billion) Population Milestones Copyright 2013 LiveScience, a TechMediaNetwork company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.source : http://www.foxnews.com/health/2013/06/14/world-population-may-reach-11-billion-by-2100/
A daily dose of powerful anti-HIV medicine helped cut the risk of infection with the AIDS virus by 49 percent in intravenous drug users in a Bangkok study that showed for the first time such a preventive step can work in this high-risk population. “This is a significant step forward for HIV prevention,” said Dr. Jonathan Mermin, director of the U.S. Centers for Disease Control and Prevention, which helped conduct the clinical trial along with the Thailand Ministry of Health. The study, published on Wednesday in the journal Lancet, looked at the treatment approach known as pre-exposure prophylaxis, or PrEP, in which HIV treatments are given to uninfected people who are at high-risk for HIV infection. The drug used in the study was Gilead's older and relatively cheap generic HIV drug tenofovir. The study was launched in 2005. Prior studies of this approach showed it cut infection rates by 44 percent in men who have sex with men, by 62 percent in heterosexual men and women and by 75 percent in couples in which one partner is infected with HIV and the other is not. The new results showed that it also protects intravenous drug users. “We now know that PrEP can work for all populations at increased risk for HIV,” Mermin said in a statement. Based on the results, the CDC plans to recommend that U.S. doctors who wish to prescribe this treatment for their patients follow the same interim guidelines issued last year to prevent sexual transmission among other high-risk individuals. Intravenous use of drugs like heroin accounts for about 8 percent of all new HIV infections in the United States and about 10 percent of new HIV infections worldwide. In some regions, such as Eastern Europe and Central Asia, injection drug abuse accounts for about 80 percent of all new infections. The new findings involved more than 2,400 intravenous drug users in Bangkok who were not infected with the human immunodeficiency virus, which causes AIDS, and were being treated at the city's drug treatment clinics. Half took tenofovir and half took a placebo. All participants were given HIV prevention counseling, risk-reduction strategies such as condoms and methadone treatment, and monthly HIV testing. At the end of the study, there were 17 HIV infections among people taking the HIV medication, compared with 33 infections among those not taking the drugs, the researchers found. The researchers also looked to see what factors influenced infection rates among those taking the HIV medication. They found that people who took their medication at least 71 percent of the time had a 74 percent lower risk of becoming infected with HIV. Although it was not clear how the preventive drug treatment worked - by stopping infections caused by sharing dirty needles or by unprotected sex among drug users - the study produced a reduction in infection rates, said Dr. Salim Abdook Karim of the University of KwaZulu-Natal in Durban, South Africa and of Columbia University in New York. “The introduction of PrEP for HIV prevention in injecting drug users should be considered as an additional component to accompany other proven prevention strategies like needle exchange programs, methadone programs, promotion of safer sex and injecting practices, condoms, and HIV counseling and testing,” Karim, who was not involved in the study, wrote in a commentary accompanying the study in the Lancet. “PrEP as part of combination prevention in injecting drug users could make a useful contribution to the quest for an AIDS-free generation,” Karim added.source : http://www.foxnews.com/health/2013/06/13/aids-drugs-halve-hiv-risk-for-intravenous-drug-users-in-study/